• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维肌痛中的症状困扰:自我招募样本中躯体症状障碍的患病率及相关因素。

Symptom Preoccupation in Fibromyalgia: Prevalence and Correlates of Somatic Symptom Disorder in a Self-Recruited Sample.

机构信息

Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

出版信息

Psychosomatics. 2020 May-Jun;61(3):268-276. doi: 10.1016/j.psym.2020.01.012. Epub 2020 Feb 10.

DOI:10.1016/j.psym.2020.01.012
PMID:32169307
Abstract

BACKGROUND

Somatic symptom disorder (SSD) is characterized by a persistent and distressing psychological reaction to somatic symptoms. In pain disorders, the preoccupation with physical symptoms is associated with poor long-term outcomes. SSD may therefore be of use to identify and help chronic pain patients with particular needs.

OBJECTIVE

To test the hypothesis that in fibromyalgia, SSD is associated with higher anxiety sensitivity, health anxiety, and reactivity to pain, in addition to lower nonreactivity to inner experiences. In addition, to investigate if individuals with SSD report a larger impact of fibromyalgia core symptoms, more somatic symptoms, and higher psychiatric comorbidity.

METHODS

Using data from a clinical trial involving self-referred individuals with fibromyalgia, we compared participants with SSD to participants without SSD using t-tests and logistic regression.

RESULTS

Forty-nine out of 140 participants (35%) had SSD. Most findings corroborate that individuals with fibromyalgia who also meet criteria for SSD are worse off in terms of traits previously found to be predictive of a poor course in pain disorders. Post hoc analyses indicated that this could not be explained merely by a higher level of fibromyalgia core symptoms.

CONCLUSION

SSD appears to be associated with a higher symptom burden in fibromyalgia, but further research is needed to draw firm conclusions regarding the reliability, acceptability, and utility of the SSD diagnosis in the clinic.

摘要

背景

躯体症状障碍(SSD)的特征是对躯体症状持续存在且令人痛苦的心理反应。在疼痛障碍中,对身体症状的过分关注与较差的长期预后相关。因此,SSD 可能有助于识别和帮助有特殊需求的慢性疼痛患者。

目的

检验假设,即 SSD 与更高的焦虑敏感、健康焦虑和对疼痛的反应性相关,而与对内在体验的低反应性相关,此外还检验 SSD 患者是否报告了更大的纤维肌痛核心症状、更多的躯体症状和更高的精神共病的假设。

方法

使用一项涉及自我报告的纤维肌痛患者的临床试验数据,我们使用 t 检验和逻辑回归比较了 SSD 患者和非 SSD 患者。

结果

140 名参与者中有 49 名(35%)患有 SSD。大多数研究结果证实,患有纤维肌痛且符合 SSD 标准的患者在先前发现与疼痛障碍不良预后相关的特征方面表现更差。事后分析表明,这不能仅仅用更高水平的纤维肌痛核心症状来解释。

结论

SSD 似乎与纤维肌痛的更高的症状负担相关,但需要进一步研究以就 SSD 诊断在临床中的可靠性、可接受性和实用性得出明确结论。

相似文献

1
Symptom Preoccupation in Fibromyalgia: Prevalence and Correlates of Somatic Symptom Disorder in a Self-Recruited Sample.纤维肌痛中的症状困扰:自我招募样本中躯体症状障碍的患病率及相关因素。
Psychosomatics. 2020 May-Jun;61(3):268-276. doi: 10.1016/j.psym.2020.01.012. Epub 2020 Feb 10.
2
Prevalence and overlap of somatic symptom disorder, bodily distress syndrome and fibromyalgia syndrome in the German general population: A cross sectional study.躯体症状障碍、躯体形式障碍和纤维肌痛综合征在德国普通人群中的患病率及重叠情况:一项横断面研究。
J Psychosom Res. 2020 Jun;133:110111. doi: 10.1016/j.jpsychores.2020.110111. Epub 2020 Apr 11.
3
Construct validity and clinical utility of current research criteria of DSM-5 somatic symptom disorder diagnosis in patients with fibromyalgia syndrome.纤维肌痛综合征患者中《精神疾病诊断与统计手册》第5版躯体症状障碍诊断现行研究标准的结构效度和临床实用性。
J Psychosom Res. 2015 Jun;78(6):546-52. doi: 10.1016/j.jpsychores.2015.03.151. Epub 2015 Mar 30.
4
Clinical value of DSM IV and DSM 5 criteria for diagnosing the most prevalent somatoform disorders in patients with medically unexplained physical symptoms (MUPS).DSM-IV 和 DSM-5 标准在诊断有无法解释的躯体症状(MUPS)的患者中最常见躯体形式障碍的临床价值。
J Psychosom Res. 2016 Mar;82:4-10. doi: 10.1016/j.jpsychores.2016.01.004. Epub 2016 Jan 12.
5
Applying the Somatic Symptom Disorder Diagnosis to Individuals with Fibromyalgia: Strengths and Limitations.将躯体症状障碍诊断应用于纤维肌痛患者:优势与局限性。
J Clin Psychol Med Settings. 2024 Sep;31(3):607-613. doi: 10.1007/s10880-024-10005-9. Epub 2024 Feb 24.
6
Classifying Fibromyalgia Syndrome as a Mental Disorder?-An Ambulatory Assessment Study.将纤维肌痛综合征归类为精神障碍?——一项门诊评估研究。
Int J Behav Med. 2017 Apr;24(2):230-238. doi: 10.1007/s12529-016-9603-6.
7
Prevalence of DSM-5 somatic symptom disorder in Chinese outpatients from general hospital care.DSM-5 躯体症状障碍在中国综合医院门诊患者中的流行情况。
Gen Hosp Psychiatry. 2020 Jan-Feb;62:63-71. doi: 10.1016/j.genhosppsych.2019.11.010. Epub 2019 Nov 29.
8
Excessiveness in Symptom-Related Thoughts, Feelings, and Behaviors: An Investigation of Somatic Symptom Disorders in the General Population.过度的症状相关思维、感觉和行为:普通人群中躯体症状障碍的调查。
Psychosom Med. 2021;83(2):164-170. doi: 10.1097/PSY.0000000000000903.
9
Comparing the diagnostic concepts of ICD-10 somatoform disorders and DSM-5 somatic symptom disorders in patients from a psychosomatic outpatient clinic.比较身心医学门诊患者中 ICD-10 躯体形式障碍和 DSM-5 躯体症状障碍的诊断概念。
J Psychosom Res. 2018 Oct;113:74-80. doi: 10.1016/j.jpsychores.2018.08.001. Epub 2018 Aug 2.
10
Psychometric properties of the Persian version of the somatic symptom disorder-B Criteria Scale (SSD-12) in community and clinical samples.躯体症状障碍-B 标准量表(SSD-12)波斯版本在社区和临床样本中的心理测量特性。
Gen Hosp Psychiatry. 2022 Sep-Oct;78:1-8. doi: 10.1016/j.genhosppsych.2022.04.010. Epub 2022 Apr 27.

引用本文的文献

1
Fibromyalgia syndrome-a bodily distress disorder/somatic symptom disorder?纤维肌痛综合征——一种身体不适障碍/躯体症状障碍?
Pain Rep. 2025 Jan 13;10(1):e1223. doi: 10.1097/PR9.0000000000001223. eCollection 2025 Feb.
2
Applying the Somatic Symptom Disorder Diagnosis to Individuals with Fibromyalgia: Strengths and Limitations.将躯体症状障碍诊断应用于纤维肌痛患者:优势与局限性。
J Clin Psychol Med Settings. 2024 Sep;31(3):607-613. doi: 10.1007/s10880-024-10005-9. Epub 2024 Feb 24.
3
Scoping review update on somatic symptom disorder that includes additional Chinese data.
关于躯体症状障碍的范围综述更新,其中纳入了更多中国数据。
Gen Psychiatr. 2023 Jun 9;36(3):e100942. doi: 10.1136/gpsych-2022-100942. eCollection 2023.
4
The frequency of psychiatric disorder co-morbidities in patients with fibromyalgia: A cross-sectional study in Iran.纤维肌痛症患者合并精神障碍的频率:伊朗的一项横断面研究。
Nurs Open. 2023 Jul;10(7):4797-4805. doi: 10.1002/nop2.1731. Epub 2023 Mar 22.
5
Altered recognition of fearful and angry facial expressions in women with fibromyalgia syndrome: an experimental case-control study.纤维肌痛综合征女性对恐惧和愤怒面部表情的识别改变:一项实验性病例对照研究。
Sci Rep. 2022 Dec 13;12(1):21498. doi: 10.1038/s41598-022-25824-9.
6
A unified Internet-delivered exposure treatment for undifferentiated somatic symptom disorder: single-group prospective feasibility trial.一种针对未分化躯体症状障碍的统一互联网暴露疗法:单组前瞻性可行性试验。
Pilot Feasibility Stud. 2022 Jul 19;8(1):149. doi: 10.1186/s40814-022-01105-0.
7
Emotional Processing and Its Association to Somatic Symptom Change in Emotional Awareness and Expression Therapy for Somatic Symptom Disorder: A Preliminary Mediation Investigation.躯体症状障碍的情绪觉知与表达疗法中的情绪加工及其与躯体症状变化的关联:一项初步中介研究。
Front Psychol. 2021 Oct 7;12:712518. doi: 10.3389/fpsyg.2021.712518. eCollection 2021.